The future of IGRT - Cost benefit analysis

Acta Oncologica

Volumn 47, Issue 7, 2008, Pages 1188-1192

  Baumann, Michael ^a   Hölscher, Tobias ^a   Zips, Daniel ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CONTROL; CANCER RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; COST BENEFIT ANALYSIS; EDITORIAL; EVIDENCE BASED MEDICINE; HEALTH CARE COST; HOSPITALIZATION; HUMAN; PRIORITY JOURNAL; SURVIVAL RATE; X RAY;

COST-BENEFIT ANALYSIS; DIAGNOSTIC IMAGING; HUMANS; RADIOTHERAPY; RADIOTHERAPY, COMPUTER-ASSISTED;

EID: 51049101306     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.1080/02841860802304556     Document Type: Editorial

References (43)

1. Muren LP, Redpath AT, Lord H, McLaren D. Image-guided radiotherapy of bladder cancer: Bladder volume variation and its relation to margins. Radiother Oncol 2007;84:307-13.
2. Guckenberger M, Meyer J, Wilbert J, Baier K, Bratengeier K, Vordermark D, et al. Precision required for dose-escalated treatment of spinal metastases and implications for image-guided radiation therapy (IGRT). Radiother Oncol 2007;84:56-63.
3. Fuller CD, Thomas CR, Jr., Wong A, Cavanaugh SX, Salter BJ, Herman TS, et al. Image-guided intensity-modulated radiation therapy for gallbladder carcinoma. Radiother Oncol 2006;81:65-72.
4. Purdie TG, Moseley DJ, Bissonnette JP, Sharpe MB, Franks K, Bezjak A, et al. Respiration correlated cone-beam computed tomography and 4DCT for evaluating target motion in Stereotactic Lung Radiation Therapy. Acta Oncol 2006;45:915-22.
5. Wurm RE, Gum F, Erbel S, Schlenger L, Scheffler D, Agaoglu D, et al. Image guided respiratory gated hypofractionated Stereotactic Body Radiation Therapy (H-SBRT) for liver and lung tumors: Initial experience. Acta Oncol 2006;45:881-9.
6. Dawson LA, Eccles C, Craig T. Individualized image guided iso-NTCP based liver cancer SBRT. Acta Oncol 2006;45:856-64.
7. Hodge W, Tome WA, Jaradat HA, Orton NP, Khuntia D, Traynor A, et al. Feasibility report of image guided stereotactic body radiotherapy (IG-SBRT) with tomotherapy for early stage medically inoperable lung cancer using extreme hypofractionation. Acta Oncol 2006;45:890-6.
8. Grosu AL, Molls M, Zimmermann FB, Geinitz H, Nusslin F, Schwaiger M, et al. High-precision radiation therapy with integrated biological imaging and tumor monitoring: Evolution of the Munich concept and future research options. Strahlenther Onkol 2006;182:361-8.
9. Sandhu A, Sethi R, Rice R, Wang JZ, Marcus L, Salem C, et al. Prostate bed localization with image-guided approach using on-board imaging: Reporting acute toxicity and implications for radiation therapy planning following prostatectomy. Radiother Oncol 2008.
10. Guckenberger M, Sweeney RA, Wilbert J, Krieger T, Richter A, Baier K, et al. Image-guided radiotherapy for liver cancer using respiratory-correlated computed tomography and cone-beam computed tomography. Int J Radiat Oncol Biol Phys 2008;71:297-304.
11. Fiorino C, Di Muzio N, Broggi S, Cozzarini C, Maggiulli E, Alongi F, et al. Evidence of limited motion of the prostate by carefully emptying the rectum as assessed by daily MVCT image guidance with helical tomotherapy. Int J Radiat Oncol Biol Phys 2008;71:611-7.
12. Grills IS, Hugo G, Kestin LL, Galerani AP, Chao KK, Wloch J, et al. Image-guided radiotherapy via daily online cone-beam CT substantially reduces margin requirements for stereotactic lung radiotherapy. Int J Radiat Oncol Biol Phys 2008;70:1045-56.
13. Kupelian PA, Langen KM, Willoughby TR, Zeidan OA, Meeks SL. Image-guided radiotherapy for localized prostate cancer: Treating a moving target. Semin Radiat Oncol 2008;18:58-66.
14. Guckenberger M, Meyer J, Wilbert J, Richter A, Baier K, Mueller G, et al. Intra-fractional uncertainties in cone-beam CT based image-guided radiotherapy (IGRT) of pulmonary tumors. Radiother Oncol 2007;83:57-64.
15. Ling CC, Yorke E, Fuks Z. From IMRT to IGRT: Frontier-land or neverland? Radiother Oncol 2006;78:119-22.
16. Mangar SA, Scurr E, Huddart RA, Sohaib SA, Horwich A, Dearnaley DP, et al. Assessing intra-fractional bladder motion using cine-MRI as initial methodology for Predictive Organ Localization (POLO) in radiotherapy for bladder cancer. Radiother Oncol 2007;85:207-14.
17. Poulsen PR, Fokdal L, Petersen J, Hoyer M. Accuracy of image-guided radiotherapy of prostate cancer based on the BeamCath urethral catheter technique. Radiother Oncol 2007;83:25-30.
18. Melancon AD, O'Daniel JC, Zhang L, Kudchadker RJ, Kuban DA, Lee AK, et al. Is a 3-mm intrafractional margin sufficient for daily image-guided intensity-modulated radiation therapy of prostate cancer? Radiother Oncol 2007;85:251-9.
19. Bral S, Van Parijs H, Soete G, Linthout N, Van Moorter L, Verellen D, et al. A feasibility study of image-guided hypofractionated conformal arc therapy for inoperable patients with localized non-small cell lung cancer. Radiother Oncol 2007;84:252-6.
20. Dawson LA, Sharpe MB. Image-guided radiotherapy: Rationale, benefits, and limitations. Lancet Oncol 2006;7:848-58.
21. Dawson LA, Jaffray DA. Advances in image-guided radiation therapy. J Clin Oncol 2007;25:938-46.
22. Verellen D, De Ridder M, Storme G. A (short) history of image-guided radiotherapy. Radiother Oncol 2008;86:4-13.
23. Verellen D, Ridder MD, Linthout N, Tournel K, Soete G, Storme G. Innovations in image-guided radiotherapy. Nat Rev Cancer 2007;7:949-60.
24. Konski A. Economic analysis of health care interventions. Semin Radiat Oncol 2008;18:168-74.
25. Steel GG. Basic clinical radiobiology. London: Arnold; 2002.
26. D'Ambrosio DJ, Pollack A, Harris EE, Price RA, Jr., Verhey LJ, Roach M, 3rd, et al. Assessment of external beam radiation technology for dose escalation and normal tissue protection in the treatment of prostate cancer. Int J Radiat Oncol Biol Phys 2008;70:671-7.
27. Baumann M, Krause M, Hill R. Exploring the role of cancer stem cells in radioresistance. Nat Rev Cancer 2008;8:545-54.
28. Miralbell R, Bleher A, Huguenin P, Ries G, Kann R, Mirimanoff RO, et al. Pediatric medulloblastoma: Radiation treatment technique and patterns of failure. Int J Radiat Oncol Biol Phys 1997;37:523-9.
29. Holthusen H. Erfahrungen über die Verträglichkeitsgrenze für Röntgenstrahlen und deren Nutzanwendung zur Verhütung von Schäden. Strahlenther 1936;57:254-69.
30. Baumann M. Keynote comment: Radiotherapy in the age of molecular oncology. Lancet Oncol 2006;7:786-7.
31. Suit H, Kooy H, Trofimov A, Farr J, Munzenrider J, DeLaney T, et al. Should positive phase III clinical trial data be required before proton beam therapy is more widely adopted? No. Radiother Oncol 2008;86:148-53.
32. Brada M, De Ruysscher D, Pijls-Johannesma M Evidence for Proton Therapy J Clin Oncol 2008.
33. Bentzen SM. Theragnostic imaging for radiation oncology: Dose-painting by numbers. Lancet Oncol 2005;6:112-7.
34. Ling CC, Humm J, Larson S, Amols H, Fuks Z, Leibel S, et al. Towards multidimensional radiotherapy (MD-CRT): Biological imaging and biological conformality. Int J Radiat Oncol Biol Phys 2000;47:551-60.
35. Geets X, Tomsej M, Lee JA, Duprez T, Coche E, Cosnard G, et al. Adaptive biological image-guided IMRT with anatomic and functional imaging in pharyngo-laryngeal tumors: Impact on target volume delineation and dose distribution using helical tomotherapy. Radiother Oncol 2007;85:105-15.
36. Gregoire V, Bol A, Geets X, Lee J. Is PET-based treatment planning the new standard in modern radiotherapy? The head and neck paradigm. Semin Radiat Oncol 2006;16:232-8.
37. Gregoire V, Haustermans K, Geets X, Roels S, Lonneux M. PET-based treatment planning in radiotherapy: A new standard? J Nucl Med 2007;48(Suppl 1):68S-77S.
38. Schutze C, Bergmann R, Yaromina A, Hessel F, Kotzerke J, Steinbach J, et al. Effect of increase of radiation dose on local control relates to pre-treatment FDG uptake in FaDu tumours in nude mice. Radiother Oncol 2007.
39. Yaromina A, Zips D, Thames HD, Eicheler W, Krause M, Rosner A, et al. Pimonidazole labelling and response to fractionated irradiation of five human squamous cell carcinoma (hSCC) lines in nude mice: The need for a multivariate approach in biomarker studies. Radiother Oncol 2006;81:122-9.
40. Quennet V, Yaromina A, Zips D, Rosner A, Walenta S, Baumann M, et al. Tumor lactate content predicts for response to fractionated irradiation of human squamous cell carcinomas in nude mice. Radiother Oncol 2006;81:130-5.
41. Grosu AL, Souvatzoglou M, Roper B, Dobritz M, Wiedenmann N, Jacob V, et al. Hypoxia imaging with FAZA-PET and theoretical considerations with regard to dose painting for individualization of radiotherapy in patients with head and neck cancer. Int J Radiat Oncol Biol Phys 2007;69:541-51.
42. Nestle U, Kremp S, Grosu AL. Practical integration of [18F]-FDG-PET and PET-CT in the planning of radiotherapy for non-small cell lung cancer (NSCLC): The technical basis, ICRU-target volumes, problems, perspectives. Radiother Oncol 2006;81:209-25.
43. Wallner PE, Konski A. The impact of technology on health care cost and policy development. Semin Radiat Oncol 2008;18:194-200.